Ryohei Otani
Tokyo Metropolitan Komagome Hospital(JP)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, MicroRNA in disease regulation, Meningioma and schwannoma management, Cancer Genomics and Diagnostics
Most-Cited Works
- → A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas(2016)261 cited
- → TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations(2020)74 cited
- → Genetic and epigenetic stability of oligodendrogliomas at recurrence(2017)52 cited
- → Distinct molecular profile of diffuse cerebellar gliomas(2017)50 cited
- → Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma(2017)48 cited
- → DNA demethylation is associated with malignant progression of lower-grade gliomas(2019)44 cited
- → Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among Facilities(2021)41 cited
- → IDH‐mutated astrocytomas with 19q‐loss constitute a subgroup that confers better prognosis(2018)28 cited
- → Selective Intracellular Delivery of Ganglioside GM3-Binding Peptide through Caveolae/Raft-Mediated Endocytosis(2017)20 cited
- → Selection bias due to delayed comprehensive genomic profiling in Japan(2022)20 cited